SANUWAVE Health, Inc. Common Stock
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses no… Read more
SANUWAVE Health, Inc. Common Stock (SNWV) - Total Assets
Latest total assets as of September 2025: $35.60 Million USD
Based on the latest financial reports, SANUWAVE Health, Inc. Common Stock (SNWV) holds total assets worth $35.60 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
SANUWAVE Health, Inc. Common Stock - Total Assets Trend (2006–2024)
This chart illustrates how SANUWAVE Health, Inc. Common Stock’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
SANUWAVE Health, Inc. Common Stock - Asset Composition Analysis
Current Asset Composition (December 2024)
SANUWAVE Health, Inc. Common Stock's total assets of $35.60 Million consist of 61.1% current assets and 38.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 34.0% |
| Accounts Receivable | $3.33 Million | 11.1% |
| Inventory | $4.15 Million | 13.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $3.73 Million | 12.4% |
| Goodwill | $7.26 Million | 24.1% |
Asset Composition Trend (2006–2024)
This chart illustrates how SANUWAVE Health, Inc. Common Stock's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: SANUWAVE Health, Inc. Common Stock's current assets represent 61.1% of total assets in 2024, a decrease from 100.0% in 2006.
- Cash Position: Cash and equivalents constituted 34.0% of total assets in 2024, down from 100.0% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 36.0% of total assets, an increase from 0.0% in 2006.
- Asset Diversification: The largest asset category is goodwill at 24.1% of total assets.
SANUWAVE Health, Inc. Common Stock Competitors by Total Assets
Key competitors of SANUWAVE Health, Inc. Common Stock based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
SANUWAVE Health, Inc. Common Stock - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - SANUWAVE Health, Inc. Common Stock generates 1.08x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - SANUWAVE Health, Inc. Common Stock is currently not profitable relative to its asset base.
SANUWAVE Health, Inc. Common Stock - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.16 | 0.12 | 0.22 |
| Quick Ratio | 0.81 | 0.08 | 0.14 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $3.06 Million | $ -71.61 Million | $ -28.25 Million |
SANUWAVE Health, Inc. Common Stock - Advanced Valuation Insights
This section examines the relationship between SANUWAVE Health, Inc. Common Stock's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 4.99 |
| Asset Growth Rate (YoY) | 34.4% |
| Total Assets | $30.12 Million |
| Market Capitalization | $150.30 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values SANUWAVE Health, Inc. Common Stock's assets at a significant premium ( 4.99x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: SANUWAVE Health, Inc. Common Stock's assets grew by 34.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for SANUWAVE Health, Inc. Common Stock (2006–2024)
The table below shows the annual total assets of SANUWAVE Health, Inc. Common Stock from 2006 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $30.12 Million | +34.36% |
| 2023-12-31 | $22.42 Million | +12.80% |
| 2022-12-31 | $19.87 Million | +6.74% |
| 2021-12-31 | $18.62 Million | -19.14% |
| 2020-12-31 | $23.03 Million | +580.89% |
| 2019-12-31 | $3.38 Million | +187.16% |
| 2018-12-31 | $1.18 Million | -7.90% |
| 2017-12-31 | $1.28 Million | +27.26% |
| 2016-12-31 | $1.00 Million | +4.85% |
| 2015-12-31 | $958.36K | -79.46% |
| 2014-12-31 | $4.67 Million | +193.84% |
| 2013-12-31 | $1.59 Million | -14.18% |
| 2012-12-31 | $1.85 Million | -69.99% |
| 2011-12-31 | $6.17 Million | +103.55% |
| 2010-12-31 | $3.03 Million | -48.37% |
| 2009-12-31 | $5.87 Million | +181768.72% |
| 2008-12-31 | $3.23K | -37.35% |
| 2007-12-31 | $5.15K | -82.96% |
| 2006-12-31 | $30.22K | -- |